Newsblaster Archived Run
Click here to return to today's news.
Friday, June 6, 2008
Articles from 06/03/2008 to 06/06/2008
Last update: 4:30 AM EST
Search for:
U.S.
World
Finance
Sci/Tech
Entertainment
Sports

View Today's Images

Back to Archive Index

About Newsblaster

About today's run

Newsblaster in Press

Academic Papers

Article Sources:
seattletimes.
nwsource.com

(142 articles)
washingtonpost.com
(142 articles)
news.bbc.co.uk
(138 articles)
nytimes.com
(128 articles)
latimes.com
(128 articles)
boston.com
(125 articles)
baltimoresun.com
(97 articles)
dallasnews.com
(83 articles)
suntimes.com
(77 articles)
sfgate.com
(75 articles)
abcnews.go.com
(68 articles)
cbc.ca
(49 articles)
nypost.com
(28 articles)
timesonline.co.uk
(26 articles)
foxnews.com
(24 articles)
ft.com
(21 articles)
sportsillustrated.
cnn.com

(12 articles)
cbsnews.com
(12 articles)
cnn.com
(11 articles)
money.cnn.com
(8 articles)
latimesblogs.
latimes.com

(6 articles)
wired.com
(5 articles)
usatoday.com
(3 articles)
health.nytimes.com
(2 articles)
swamppolitics.com
(2 articles)
haaretz.com
(2 articles)
blog.wired.com
(2 articles)








Science/Technology
F.D.A. Reviews Arthritis Drugs for Links to Cancer (Science/Technology, 6 articles)
The Food and Drug Administration said Wednesday that it was investigating whether four drugs used to treat rheumatoid arthritis and other immune system diseases might increase the risk of cancer in children. Amgen's multibillion-dollar anemia drug Aranesp is facing further safety concerns after a medical newsletter reported that a Danish study of the drug in head and neck cancer was halted as a result of adverse outcomes in patients taking part. The development was reported in The Cancer Letter, which said the study was temporarily halted in October after an interim analysis of the first 484 patients turned up a statistically significant increase in disease recurrence. The FDA began investigating cancer cases linked to the class of medicines, known as TNF blockers, which also includes Abbott Laboratories' Humira, 10 years ago. " While the review is ongoing, FDA advises prescribers to weigh the possible association with lymphoma and other cancers against the benefits of treatment when prescribing TNF blockers to children and young adults the agency said. WASHINGTON - Federal regulators are investigating whether a group of best-selling arthritis drugs made by Abbott Laboratories, Schering-Plough Corp. and other companies heighten the risk of cancer in youngsters.
Other stories about cancer, patients and children:
  • Pediatric cancer most common in N.E., study shows - (5 articles)


  • Study secretly tracked cellphone users (Science/Technology, 6 articles)
    In a study designed to track how large-scale disease might spread, researchers have made a not-so-surprising discovery: Most people are slaves to routine and tend to stay close to home. Over the course of six months, three Northeastern University researchers tracked cell phone users in Europe in search of information on human travel patterns that could be used in disease epidemic prevention and urban planning. Additionally, for one week, the researchers followed a group of 206 cell phone users equipped with programs that allowed their location to be recorded every two hours by their cell phone company.
    Red wine shows new promise in search to enhance longevity (Science/Technology, 5 articles)
    NEW YORK - Red wine may be much more potent than was thought in extending the human lifespan, researchers say in a new report that is likely to give impetus to the rapidly growing search for longevity drugs. On Monday, Sirtris, founded in 2004 to develop drugs with the same effects as resveratrol, completed its sale to GlaxoSmithKline for $720 million. A group of scientists at the University of Wisconsin at Madison says there is a new reason to toast to the benefits of red wine.


    Crew fixes space station toilet, opens science lab (Science/Technology, 8 articles)
    CAPE CANAVERAL, Fla. - To everybody's relief, astronauts fixed the toilet at the International Space Station yesterday and opened up a grand new science lab. The toilet problem had fast become the most pressing issue of the mission, so much so that a spare pump was rushed from Moscow to Cape Canaveral last week for a last-minute ride aboard space shuttle Discovery. CAPE CANAVERAL, Fla. - Spacewalking astronauts worked on the outside of Japan's shiny new science lab Thursday, installing cameras and removing covers.




    blaster@cs.columbia.edu